ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $376,906 | -6.0% | 25,398 | -13.6% | 0.00% | 0.0% |
| Q1 2024 | $400,989 | -65.3% | 29,398 | -72.1% | 0.00% | -80.0% |
| Q3 2023 | $1,155,816 | -20.7% | 105,554 | -4.1% | 0.01% | -16.7% |
| Q2 2023 | $1,456,691 | -0.2% | 110,022 | +2.6% | 0.01% | 0.0% |
| Q1 2023 | $1,459,291 | -15.3% | 107,222 | +21.6% | 0.01% | -25.0% |
| Q4 2022 | $1,722,507 | +3.0% | 88,198 | +0.4% | 0.01% | -11.1% |
| Q3 2022 | $1,673,000 | -34.9% | 87,826 | -29.6% | 0.01% | -30.8% |
| Q2 2022 | $2,571,000 | +145.1% | 124,797 | +282.8% | 0.01% | +225.0% |
| Q1 2022 | $1,049,000 | – | 32,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |